---
title: "4D PHARMA RESEARCH LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/f63ee81a-fa64-54c7-91aa-d4bd3460fdbc
json: https://whiteintel.dev/api/public/dossier/f63ee81a-fa64-54c7-91aa-d4bd3460fdbc
identifier: oo:GB-COH-SC336222
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# 4D PHARMA RESEARCH LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-SC336222`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/f63ee81a-fa64-54c7-91aa-d4bd3460fdbc  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/f63ee81a-fa64-54c7-91aa-d4bd3460fdbc  

## Ownership & control

### Owners / controllers

- **4D PHARMA PLC** (beneficial owner) — 100% — https://whiteintel.dev/entity/778edb04-9a28-5e4c-b04a-c71b11d6734e
- **4D PHARMA PLC** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/778edb04-9a28-5e4c-b04a-c71b11d6734e

### UBO chain (walk to the ultimate owner)

A **10-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `SC336222`
- **Status:** dissolved
- **Type:** ltd
- **Incorporated:** 2008-01-15
- **Registered office:** C/O Interpath Limited 5th Floor, 130 St. Vincent Street, Glasgow, G2 5HF
- **SIC:** 72110

### Officers

- DALE, Laurence Smith — secretary · appointed 2012-11-20 · resigned 2020-01-31
- PEYTON, Duncan — secretary · appointed 2020-01-31 · resigned 2023-03-16
- WINTON, Keith David Roy, Dr — secretary · British · appointed 2008-03-12 · resigned 2012-11-12
- MACLAY MURRAY & SPENS LLP — corporate nominee secretary · appointed 2008-01-15 · resigned 2008-03-12
- ENGELEN, Thomas — director · Dutch · appointed 2012-11-12 · resigned 2015-04-30
- KELLY, Denise, Professor — director · British · appointed 2008-03-12 · resigned 2013-10-04
- MARRIGE, Howard John, Dr — director · British · appointed 2008-03-12 · resigned 2012-09-04
- PEYTON, Duncan Joseph — director · British · appointed 2012-11-12 · resigned 2023-03-17
- STEVENSON, Alexander James — director · British · appointed 2013-09-11 · resigned 2023-03-17
- THOMSON, Douglas Campbell — director · British · appointed 2013-09-11 · resigned 2015-12-31
- VINDEX LIMITED — corporate nominee director · appointed 2008-01-15 · resigned 2008-03-12
- VINDEX SERVICES LIMITED — corporate nominee director · appointed 2008-01-15 · resigned 2008-03-12

### Beneficial owners (Persons with Significant Control)

- [4d Pharma Plc](https://whiteintel.dev/entity/778edb04-9a28-5e4c-b04a-c71b11d6734e) — 75–100% shares · corporate PSC · England — since 2016-04-06

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/SC336222

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **4D PHARMA RESEARCH LIMITED** — https://whiteintel.dev/entity/f63ee81a-fa64-54c7-91aa-d4bd3460fdbc · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **4D PHARMA RESEARCH LIMITED**. Human view: https://whiteintel.dev/entity/f63ee81a-fa64-54c7-91aa-d4bd3460fdbc · Structured JSON: https://whiteintel.dev/api/public/dossier/f63ee81a-fa64-54c7-91aa-d4bd3460fdbc._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._